Cannabidiol (CBD) Use in Type 2 Diabetes: A Case Report.
作者信息
Mattes Raymond G, Espinosa Melchor L, Oh Sam S, Anatrella Elizabeth M, Urteaga Elizabeth M
机构信息
Feik School of Pharmacy, University of the Incarnate Word, San Antonio, TX.
Cleveland Clinic, Cleveland, OH.
出版信息
Diabetes Spectr. 2021 May;34(2):198-201. doi: 10.2337/ds20-0023. Epub 2021 Dec 23.
Abstract
摘要
相似文献
1
Cannabidiol (CBD) Use in Type 2 Diabetes: A Case Report.大麻二酚（CBD）在2型糖尿病中的应用：一例报告
Diabetes Spectr. 2021 May;34(2):198-201. doi: 10.2337/ds20-0023. Epub 2021 Dec 23.
2
Cannabidiol arrests onset of autoimmune diabetes in NOD mice.大麻二酚可阻止非肥胖糖尿病（NOD）小鼠自身免疫性糖尿病的发病。
Neuropharmacology. 2008 Jan;54(1):244-9. doi: 10.1016/j.neuropharm.2007.06.029. Epub 2007 Jul 17.
3
Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol-dimethylheptyl at the type 1 and type 2 cannabinoid receptors.大麻二酚和大麻二酚-二甲基庚基在大麻素受体 1 型和 2 型上的变构和正构药理学。
Br J Pharmacol. 2019 May;176(10):1455-1469. doi: 10.1111/bph.14440. Epub 2018 Aug 10.
4
Cannabidiol Enhances Intestinal Cannabinoid Receptor Type 2 Receptor Expression and Activation Increasing Regulatory T Cells and Reduces Murine Acute Graft-versus-Host Disease without Interfering with the Graft-versus-Leukemia Response.大麻二酚增强肠道大麻素受体 2 型受体表达和激活，增加调节性 T 细胞，减少小鼠急性移植物抗宿主病，而不干扰移植物抗白血病反应。
J Pharmacol Exp Ther. 2021 May;377(2):273-283. doi: 10.1124/jpet.120.000479. Epub 2021 Mar 3.
5
Cannabidiol induces antidepressant and anxiolytic-like effects in experimental type-1 diabetic animals by multiple sites of action.大麻二酚通过多种作用机制在实验性 1 型糖尿病动物中诱导抗抑郁和抗焦虑样作用。
Metab Brain Dis. 2021 Apr;36(4):639-652. doi: 10.1007/s11011-020-00667-3. Epub 2021 Jan 19.
6
Don't Fear the Reefer-Evidence Mounts for Plant-Based Cannabidiol as Treatment for Epilepsy.别怕大麻二酚——植物性大麻二酚作为癫痫治疗手段的证据不断增加。
Epilepsy Curr. 2019 Mar-Apr;19(2):93-95. doi: 10.1177/1535759719835671.
7
Effects of Cannabidiol on Diabetes Outcomes and Chronic Cerebral Hypoperfusion Comorbidities in Middle-Aged Rats.大麻二酚对中年大鼠糖尿病结局和慢性大脑低灌注合并症的影响。
Neurotox Res. 2019 Feb;35(2):463-474. doi: 10.1007/s12640-018-9972-5. Epub 2018 Nov 14.
8
Motor effects of the non-psychotropic phytocannabinoid cannabidiol that are mediated by 5-HT1A receptors.由5-羟色胺1A受体介导的非精神活性植物大麻素大麻二酚的运动效应。
Neuropharmacology. 2013 Dec;75:155-63. doi: 10.1016/j.neuropharm.2013.07.024. Epub 2013 Aug 4.
9
The effect of cannabidiol on ischemia/reperfusion-induced ventricular arrhythmias: the role of adenosine A1 receptors.大麻二酚对缺血/再灌注诱导的室性心律失常的影响：腺苷A1受体的作用。
J Cardiovasc Pharmacol Ther. 2015 Jan;20(1):76-83. doi: 10.1177/1074248414532013. Epub 2014 May 22.
10
Cannabidiol (CBD): Perspectives from Pinterest.大麻二酚（CBD）：来自Pinterest的观点。
Subst Use Misuse. 2020;55(13):2213-2220. doi: 10.1080/10826084.2020.1797808. Epub 2020 Jul 25.
引用本文的文献
1
Use of Cannabidiol-Dominant Extract as Co-Adjuvant Therapy for Type 2 Diabetes Mellitus Treatment in Feline: Case Report.使用以大麻二酚为主的提取物作为猫 2 型糖尿病治疗的辅助疗法：病例报告。
Med Cannabis Cannabinoids. 2024 Sep 14;7(1):206-212. doi: 10.1159/000541034. eCollection 2024 Jan-Dec.
2
Rational drug repositioning for coronavirus-associated diseases using directional mapping and side-effect inference.利用定向映射和副作用推断对冠状病毒相关疾病进行合理的药物重新定位。
iScience. 2022 Nov 18;25(11):105348. doi: 10.1016/j.isci.2022.105348. Epub 2022 Oct 13.
本文引用的文献
1
Potential Clinical Benefits of CBD-Rich Extracts Over Purified CBD in Treatment-Resistant Epilepsy: Observational Data Meta-analysis.富含大麻二酚（CBD）的提取物相较于纯化CBD在难治性癫痫治疗中的潜在临床益处：观察性数据荟萃分析
Front Neurol. 2018 Sep 12;9:759. doi: 10.3389/fneur.2018.00759. eCollection 2018.
2
An interaction between warfarin and cannabidiol, a case report.华法林与大麻二酚的相互作用：一例报告
Epilepsy Behav Case Rep. 2017 Oct 12;9:10-11. doi: 10.1016/j.ebcr.2017.10.001. eCollection 2018.
3
Efficacy and Safety of Cannabidiol and Tetrahydrocannabivarin on Glycemic and Lipid Parameters in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Pilot Study.二型糖尿病患者使用大麻二酚和四氢大麻酚素对血糖和血脂参数的疗效和安全性：一项随机、双盲、安慰剂对照、平行分组的初步研究。
Diabetes Care. 2016 Oct;39(10):1777-86. doi: 10.2337/dc16-0650. Epub 2016 Aug 29.
4
Cannabinoids for Medical Use: A Systematic Review and Meta-analysis.医用大麻素：系统评价和荟萃分析。
JAMA. 2015;313(24):2456-73. doi: 10.1001/jama.2015.6358.
5
Exogenous cannabinoids as substrates, inhibitors, and inducers of human drug metabolizing enzymes: a systematic review.外源性大麻素作为人药物代谢酶的底物、抑制剂和诱导剂：系统评价。
Drug Metab Rev. 2014 Feb;46(1):86-95. doi: 10.3109/03602532.2013.849268. Epub 2013 Oct 25.
6
Involvement of UDP-glucuronosyltransferases UGT1A9 and UGT2B7 in ethanol glucuronidation, and interactions with common drugs of abuse.UGT1A9 和 UGT2B7 在乙醇葡萄糖醛酸化中的作用，以及与常见滥用药物的相互作用。
Drug Metab Dispos. 2013 Mar;41(3):568-74. doi: 10.1124/dmd.112.047878. Epub 2012 Dec 10.
7
Diabetic retinopathy: Role of inflammation and potential therapies for anti-inflammation.糖尿病性视网膜病变：炎症的作用及抗炎的潜在疗法。
World J Diabetes. 2010 Mar 15;1(1):12-8. doi: 10.4239/wjd.v1.i1.12.
8
Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy.大麻二酚可减轻糖尿病心肌病中心功能障碍、氧化应激、纤维化以及炎症和细胞死亡信号通路。
J Am Coll Cardiol. 2010 Dec 14;56(25):2115-25. doi: 10.1016/j.jacc.2010.07.033.
9
Cannabinoid receptors: where they are and what they do.大麻素受体：其所在位置及功能
J Neuroendocrinol. 2008 May;20 Suppl 1:10-4. doi: 10.1111/j.1365-2826.2008.01671.x.
10
Cannabidiol attenuates high glucose-induced endothelial cell inflammatory response and barrier disruption.大麻二酚可减轻高糖诱导的内皮细胞炎症反应和屏障破坏。
Am J Physiol Heart Circ Physiol. 2007 Jul;293(1):H610-9. doi: 10.1152/ajpheart.00236.2007. Epub 2007 Mar 23.
Zotero 插件